Extracorporeal photopheresis (ECP) is a relatively new and promising alternative
therapeutic modality. It simply is the extracorporeal treatment of a particular subset of cells …

Background Localized scleroderma (LS) comprises a spectrum of sclerotic autoimmune
diseases primarily affecting the dermis. Various treatment modalities have been …

The treatment of sclerosing skin diseases [systemic sclerosis, localized scleroderma, lichen
sclerosus et atrophicus, sclerodermoid graft‐vs.‐host disease, scleredema adultorum …

The use of photochemotherapy for the treatment of cutaneous T-cell lymphoma (CTCL) was
first reported by Gilchrest et al. in 1976. 1 Oral 8-methoxypsoralen (8MOP) was administered …

Scleroderma is a chronic disease of connective tissue characterized by deposition of large
amounts of collagen. Localized scleroderma affects only the skin, whereas systemic …

BACKGROUND: Scleroderma is a chronic autoimmune disease characterized by
progressive connective tissue sclerosis and microcirculatory changes. Localized …

Morphea, or localized scleroderma, can at times constitute a severely disabling and
aggressive disease with no single therapy proven to be curative or the standard of care …

Extracorporeal photopheresis is a new form of immunotherapy that involves the use of a
leukapheresis device that permits the extracorporeal exposure of potentially pathogenic …

Scleromyxedema is an uncommon disease of unclear etiology. Therapy is difficult. Two
patients with scleromyxedema were treated with extracorporeal photopheresis (ECP). The …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy which involves separation of the patient's leucocyte‐rich plasma, followed by ex vivo …